Jinyu Bio-Technology Co

Jinyu Bio-Technology Co Short-term Debt

The Short-Term Debt of Jinyu Bio-Technology Co (600201.SS) as of Oct 27, 2026 is 15.01 M CNY. In the previous year, Short-Term Debt was 10.01 M CNY — a change of 49.90% (higher).

Short-term Debt

15.01 MCNY

YoY

49.90%

Last updated:

Short-Term Debt of Jinyu Bio-Technology Co is 2024 15.01 M CNY. Short-Term Debt of Jinyu Bio-Technology Co was 2023 10.01 M CNY. It decreases by 49.90% higher compared to the previous year.

The Jinyu Bio-Technology Co Short-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Short-term Debt
Date
Short-term Debt
Jan 1, 2015
500,000.00 CNY
Jan 1, 2019
25.00 M CNY
Jan 1, 2022
10.01 M CNY
Jan 1, 2024
15.01 M CNY
The Jinyu Bio-Technology Co Short-term Debt history
YEARShort-term DebtYoY
15.01 MCNY+49.90%
10.01 MCNY-59.95%
25.00 MCNY+4,900.00%
500,000.00CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jinyu Bio-Technology Co Stock analysis

What does Jinyu Bio-Technology Co do? Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas. Jinyu Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jinyu Bio-Technology Co stock

Short-Term Debt of Jinyu Bio-Technology Co is 15.01 M CNY in 2024.

Short-Term Debt of Jinyu Bio-Technology Co changed from 10.01 M CNY to 15.01 M CNY, representing a 49.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Short-Term Debt Jinyu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

Short-term debt represents borrowings due within one year. High short-term debt relative to cash can signal liquidity risk.

Short-Term Debt's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Short-Term Debt's Jinyu Bio-Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Jinyu Bio-Technology Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Jinyu Bio-Technology Co